Get the Stockscreener App
103.79
2.97%
2.99
Pre-market:
104.66
0.87
+0.84%
Boston Scientific Corp stock is traded at $103.79, with a volume of 8.22M.
It is up +2.97% in the last 24 hours and up +1.40% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
See More
Previous Close:
$100.80
Open:
$101.13
24h Volume:
8.22M
Relative Volume:
1.51
Market Cap:
$153.17B
Revenue:
$16.75B
Net Income/Loss:
$1.85B
P/E Ratio:
83.03
EPS:
1.25
Net Cash Flow:
$2.37B
1W Performance:
-0.67%
1M Performance:
+1.40%
6M Performance:
+26.90%
1Y Performance:
+56.76%
1-Day Range:
$101.01
$104.10
1-Week Range:
$97.08
$104.95
52-Week Range:
$65.52
$107.17
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
103.79 | 153.17B | 16.75B | 1.85B | 2.37B | 1.25 |
|
ABT
Abbott Laboratories
|
138.01 | 239.35B | 41.95B | 13.40B | 6.35B | 7.65 |
|
SYK
Stryker Corp
|
386.19 | 147.36B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.02 | 118.00B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.62 | 42.24B | 5.72B | 4.17B | 490.10M | 6.97 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
| Oct-18-24 | Downgrade | Needham | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-22-22 | Initiated | Mizuho | Neutral |
| Dec-20-22 | Resumed | Citigroup | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-06-22 | Initiated | Wolfe Research | Outperform |
| May-27-22 | Upgrade | Needham | Hold → Buy |
| Apr-13-22 | Resumed | Truist | Buy |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| May-26-21 | Downgrade | Needham | Buy → Hold |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Buy |
| Dec-30-19 | Reiterated | Cowen | Outperform |
| Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
| Sep-05-19 | Resumed | JP Morgan | Overweight |
| Sep-03-19 | Resumed | Barclays | Overweight |
| May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
| Sep-07-18 | Reiterated | Needham | Strong Buy |
| Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
| Jul-06-18 | Reiterated | Needham | Strong Buy |
| Jun-27-18 | Initiated | Bernstein | Outperform |
| Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
The Zacks Analyst Blog The Goldman Sachs, The Progressive, Boston Scientific and Cooper-Standard - Nasdaq
Cavalier Investments LLC Raises Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Bank of New York Mellon Corp Has $1.11 Billion Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Top Stock Reports for Goldman Sachs, Progressive & Boston Scientific - Yahoo Finance
Insider Selling: Boston Scientific Co. (NYSE:BSX) EVP Sells 4,675 Shares of Stock - MarketBeat
Consilium Wealth Advisory LLC Raises Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Kidney Stone Retrieval Devices Market to Cross $4.8 Billion by 2034, Fueled by Rising Awareness and New Technologies | Exclusive Report by Transparency Market Research Inc. - GlobeNewswire Inc.
April 11th Options Now Available For Boston Scientific (BSX) - Nasdaq
Boston Scientific Corporation (BSX): Among Stocks to Invest In from Israel Englander’s Portfolio - Insider Monkey
Boston Scientific Co. (NYSE:BSX) Shares Acquired by Alecta Tjanstepension Omsesidigt - MarketBeat
New York Life Investment Management LLC Raises Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Fisher Funds Management LTD Buys New Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Stake Raised by HealthInvest Partners AB - MarketBeat
Boston Scientific Announces Completion Of EUR1.5 Billion Offering Of Senior Notes - Marketscreener.com
Boston Scientific announces completion of €1.5 billion offering of senior notes - Quantisnow
Catheter Market Global Report and Company Analysis 2025-2033 Featuring Abbott Laboratories, BD and Co, Boston Scientific, Teleflex, Medtronic, Johnson & Johnson, Edwards Lifesciences, Stryker - Yahoo Finance
Atria Wealth Solutions Inc. Boosts Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific’s SWOT analysis: innovative medtech stock poised for growth - Investing.com
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today - Benzinga
Boston Scientific Recalls Accolade Pacemaker Devices - The Rochester Sentinel
Boston Scientific reports first cases with next-gen Faraflex catheter - Mass Device
Boston Scientific Co. (NYSE:BSX) Stock Position Lessened by Bradley Foster & Sargent Inc. CT - MarketBeat
Boston Scientific director Zane Ellen M sells $1.42 million in stock By Investing.com - Investing.com South Africa
StockNews.com Downgrades Boston Scientific (NYSE:BSX) to Hold - MarketBeat
Boston Scientific director Zane Ellen M sells $1.42 million in stock - Investing.com India
Boston Scientific Director Sells Over $1.4 Million in Company Stock - TradingView
Boston Scientific Loses Patent For Flexible Stent On Appeal - Law360
Boston Scientific prices $1.6B public offering - Mass Device
Balloon Catheters Patent Landscape Report 2025, with - GlobeNewswire
Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System - Yahoo Finance
What Does the Market Think About Boston Scientific? - Benzinga
Truist Financial Corp Sells 4,801 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific's SVP Vance Brown sells $504,992 in stock By Investing.com - Investing.com Australia
TKG Advisors LLC Boosts Stock Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Announces Pricing Of EUR1.5 Billion Of Senior Notes -February 22, 2025 at 03:16 am EST - Marketscreener.com
Boston Scientific Co. (NYSE:BSX) Shares Sold by New York State Common Retirement Fund - MarketBeat
Boston Scientific announces pricing of €1.5 billion of senior notes - The Malaysian Reserve
Boston Scientific's American Medical Systems Europe Prices EUR 1.5 Bln Of Senior Notes - Nasdaq
Boston Scientific raises €1.5bn after double upgrade - GlobalCapital
Boston Scientific's SVP Vance Brown sells $504,992 in stock - Investing.com India
Boston Scientific’s SVP Vance Brown sells $504,992 in stock By Investing.com - Investing.com Nigeria
BSX: 3 Medical Device Stocks Seeing Surge in Demand - StockNews.com
FDA Boston Scientific Corporation Recalls Accolade Pacemaker Devices Due To Manufacturing Issue That May Lead To Early Device Replacement - Marketscreener.com
Boston Scientific hired 5,000 new employees, increased real estate footprint in 2024 - NBC Boston
Boston Scientific ramped up headcount, real estate footprint in 2024 - The Business Journals
Boston Scientific Co. (NYSE:BSX) CFO Daniel J. Brennan Sells 67,333 Shares - MarketBeat
Boston Sci obtains CE mark for Farapulse navigation mapping system - BioWorld Online
Boston Scientific Co. (NYSE:BSX) EVP Sells $277,417.37 in Stock - MarketBeat
Boston Scientific Expects Strong Gains in 2025: Time to Buy the Stock? - Yahoo Finance
Boston Scientific Corp. credit rating upgraded to ’A-’ on strong performance: S&P Global - Investing.com Nigeria
Private Wealth Partners LLC Sells 3,895 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.70%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):